Related Experiment Video
Updated: Mar 18, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.3K
Inflammatory pathway network-based drug repositioning and molecular phenomics.
Jiangyong Gu1, Philip S Crosier2, Christopher J Hall2
1Beijing National Laboratory for Molecular Sciences, State Key Lab of Rare Earth Material Chemistry and Applications, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China. lirongc@pku.edu.cn xiaojxu@pku.edu.cn.
Molecular Biosystems
|June 28, 2016
Summary
This study models inflammation pathways to predict new anti-inflammatory drugs. The approach uses network analysis and approved drug screening for faster, cheaper drug repositioning and mechanism insights.
Area of Science:
- Immunology
- Systems Biology
- Pharmacology
Background:
- Inflammation is a critical biological response involving immune cells, blood vessels, and mediators.
- Understanding inflammation pathways is key to developing effective treatments.
- Current drug discovery for anti-inflammatory agents can be time-consuming and expensive.
Purpose of the Study:
- To construct a comprehensive pathway network of inflammation.
- To develop a predictive model for identifying potential anti-inflammatory drugs.
- To explore drug repositioning for existing medications to treat inflammatory conditions.
Main Methods:
- Construction of an inflammation pathway network encompassing 11 sub-pathways.
- Application of network efficiency and network flux analyses to assess drug efficacy.
- Development of a predictive model using validated anti-inflammatory drugs for training.
- Screening of approved drugs in DrugBank for potential anti-inflammatory activity.
Main Results:
- A functional pathway network for inflammation was successfully constructed.
- The model effectively identified potential anti-inflammatory candidates from approved drugs.
- Demonstrated the utility of network-based approaches for drug repositioning.
- Highlighted the value of molecular phenomics for understanding drug mechanisms.
Conclusions:
- Pathway network analysis provides a robust framework for evaluating anti-inflammatory drug efficacy.
- Drug repositioning using this model offers a rapid and cost-effective strategy for discovering new therapeutic indications.
- Molecular phenomics data can elucidate the mechanisms of action for anti-inflammatory drugs.
More Related Videos
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
73
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73
01:26Drug Discovery: Overview
12.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.8K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
98
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
98
01:28Structure-Activity Relationships and Drug Design
2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K
01:27Pharmacogenetics of Drug Metabolism: Overview
96
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
96
01:29Pharmacogenetics and Pharmacogenomics: Overview
132
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
132